Clinical trial
Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
NCT00003602 · Riverside Haematology Group, Other · Unknown status
Key facts
| NCT number | NCT00003602 |
|---|---|
| Title | Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia |
| Official title | A Randomised Study Comparing an Oral Regimen (Idarubicin and Etoposide) With an Intravenous Regimen (MAE) for Consolidation in Patients Over 55 Years With Acute Myeloid Leukaemia in First Complete Remission |
| Lead sponsor | Riverside Haematology Group, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia, Myelodysplastic Syndromes |
| Intervention type | Drug |
| Interventions | cytarabine, etoposide, idarubicin, mitoxantrone hydrochloride |
| Enrollment | 400 |
| Start date | Mar 1, 1998 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 20, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: